Axel Bolte
2023
In 2023, Axel Bolte earned a total compensation of $1.8M as Former President and Chief Executive Officer at Inozyme Pharma, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,250 |
|---|---|
| Option Awards | $638,860 |
| Salary | $170,327 |
| Other | $882,506 |
| Total | $1,796,943 |
Bolte received $882.5K in other compensation, accounting for 49% of the total pay in 2023.
Bolte also received $105.3K in non-equity incentive plan, $638.9K in option awards and $170.3K in salary.
Rankings
In 2023, Axel Bolte's compensation ranked 608th out of 2,918 executives tracked by ExecPay. In other words, Bolte earned more than 79.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 608 out of 2,918 | 79th |
Division Manufacturing | 345 out of 1,608 | 79th |
Major group Chemicals And Allied Products | 238 out of 901 | 74th |
Industry group Drugs | 234 out of 864 | 73rd |
Industry Pharmaceutical Preparations | 149 out of 622 | 76th |
Source: SEC filing on April 26, 2024.
Bolte's colleagues
We found three more compensation records of executives who worked with Axel Bolte at Inozyme Pharma in 2023.